CNTX CIK: 1842952

Context Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.5
FY22:
−15.4
FY23:
−25.1
FY24:
−29.9
FY25:
−39.7
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−25.1
FY24:
−29.9
FY25:
−39.7
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−24.0
FY24:
−26.7
FY25:
−36.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.5
FY22:
−14.8
FY23:
−24.0
FY24:
−26.7
FY25:
−36.1

All amounts in millions USD Data sources:SEC EDGARTwelve Data